Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia

E Kövari1, G Gold, F R Herrmann

  • 1Department of Psychiatry, University of Geneva School of Medicine, Chêne-Bourg, Switzerland. eniko.kovari@hcuge.ch

Neurology
|March 21, 2007
PubMed
Abstract

Insights

Microvascular lesions, specifically cortical microinfarcts and periventricular demyelination, significantly contribute to cognitive decline in individuals at high risk for dementia. These findings are crucial for diagnosing mixed dementia.

Area of Science:

  • Neuropathology
  • Neurodegenerative Diseases
  • Vascular Neurology

Background:

  • Alzheimer disease (AD) pathology is often mixed with other pathologies, including microvascular lesions.
  • Understanding the contribution of these mixed pathologies to cognitive decline is crucial for accurate diagnosis and treatment.

Purpose of the Study:

  • To investigate the synergistic effect of microvascular lesions and mild Alzheimer disease pathology in mixed dementia cases.
  • To assess the cognitive impact of specific microvascular lesions in individuals with early AD pathology.

Main Methods:

  • Assessed cognitive impact of cortical microinfarcts, white matter demyelination, and gliosis in 43 autopsy cases with Braak stage III neurofibrillary tangles.
  • Used multivariate models controlling for age and amyloid-beta (Abeta) deposits, with bilateral assessment of microvascular lesions.

Main Results:

  • Cortical microinfarcts and periventricular demyelination were significantly associated with Clinical Dementia Rating (CDR) scores.
  • Cortical microinfarcts explained 9% and periventricular demyelination 7.3% of CDR variability, while Abeta deposition explained only 3.5% in univariate models.
  • In logistic regression, both microinfarcts and demyelination strongly predicted dementia presence (R=0.45, p<0.05); adding them to Abeta staging significantly increased cognitive variability prediction.

Conclusions:

  • Cortical microinfarcts and periventricular demyelination contribute to cognitive decline in individuals at high risk for dementia.
  • These vascular lesions should be considered in the neuropathologic criteria for mixed dementia.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...